CYNTHIA DUPREY: Open Payments
NPI 1780026013 · HOLLY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 40 payments from 18 companies in 2025. Trend: 2023 $546 · 2024 $748 · 2025 $1,272
Food & beverage: $1,194Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $250 |
| AstraZeneca Pharmaceuticals LP | 3 | $166 |
| Daiichi Sankyo Inc. | 7 | $146 |
| Karyopharm Therapeutics Inc. | 2 | $130 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| PFIZER INC. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $52 |
| ABBVIE INC. | 2 | $48 |
Products named: RYBREVANT, XPOVIO, ENHERTU, KEYTRUDA, DARZALEX, KISQALI, NINLARO, VERZENIO.
Industry payments across GA — which companies pay providers there.
